Exploring nanoformulation drug delivery of herbal actives for enhanced therapeutic efficacy: A comprehensive review

Divyanshi Sharma, Arti Gupta, Reetika Rawat, Shipra Sharma, Jitendra Singh Yadav, Anshika Saxena
{"title":"Exploring nanoformulation drug delivery of herbal actives for enhanced therapeutic efficacy: A comprehensive review","authors":"Divyanshi Sharma,&nbsp;Arti Gupta,&nbsp;Reetika Rawat,&nbsp;Shipra Sharma,&nbsp;Jitendra Singh Yadav,&nbsp;Anshika Saxena","doi":"10.1016/j.ipha.2024.07.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In this present review we have focused on nanoformulation drug delivery approach to deliver active drug constituents. As it can minimizes the limitations associated with conventional therapies such as rapid gastric emptying, high surface area, site specific controlled drug delivery high cellular uptake, improved bioavailability, cost effectiveness, patient compliance, and improved therapeutic efficacy of drug along with reduction in systemic and local toxicity by governing the drug release behaviour.</div></div><div><h3>Purpose</h3><div>Over the years, nanoparticles have emerged as an amazing dosage form owing to their advantages such as permeability across barriers, controlled drug release and higher stability. They can be linked to specific ligands which can allow the development of targeted therapies. Hence, targeted treatments of nanoformulations for asthma and sepsis may help to maximize therapeutic benefit and helps to lower their severity.</div></div><div><h3>Conclusion</h3><div>This review highlights the nanoformulations and their potential application in drug delivery. Mechanism of action of various phytoconstituents such as flavonoids and triterpenoids is also discussed. The flavonoid as well as triterpenoid loaded nanoparticles seems to be a promising drug delivery systems, especially on account of account of its management in inflammatory diseases.</div></div>","PeriodicalId":100682,"journal":{"name":"Intelligent Pharmacy","volume":"3 1","pages":"Pages 26-34"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intelligent Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949866X24000820","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

In this present review we have focused on nanoformulation drug delivery approach to deliver active drug constituents. As it can minimizes the limitations associated with conventional therapies such as rapid gastric emptying, high surface area, site specific controlled drug delivery high cellular uptake, improved bioavailability, cost effectiveness, patient compliance, and improved therapeutic efficacy of drug along with reduction in systemic and local toxicity by governing the drug release behaviour.

Purpose

Over the years, nanoparticles have emerged as an amazing dosage form owing to their advantages such as permeability across barriers, controlled drug release and higher stability. They can be linked to specific ligands which can allow the development of targeted therapies. Hence, targeted treatments of nanoformulations for asthma and sepsis may help to maximize therapeutic benefit and helps to lower their severity.

Conclusion

This review highlights the nanoformulations and their potential application in drug delivery. Mechanism of action of various phytoconstituents such as flavonoids and triterpenoids is also discussed. The flavonoid as well as triterpenoid loaded nanoparticles seems to be a promising drug delivery systems, especially on account of account of its management in inflammatory diseases.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
探索中草药活性成分的纳米配方给药,以提高疗效:综述
在这篇综述中,我们主要关注纳米制剂药物递送方法来递送活性药物成分。因为它可以最大限度地减少与传统疗法相关的局限性,如快速胃排空,高表面积,部位特异性控制药物递送,高细胞摄取,提高生物利用度,成本效益,患者依从性,以及通过控制药物释放行为降低全身和局部毒性来提高药物的治疗效果。近年来,纳米颗粒由于其具有穿透屏障、药物释放可控和稳定性高等优点,成为一种令人惊叹的剂型。它们可以与特定的配体连接,从而可以开发靶向治疗。因此,针对哮喘和败血症的纳米制剂的靶向治疗可能有助于最大限度地提高治疗效益,并有助于降低其严重程度。结论综述了纳米制剂及其在给药领域的应用前景。讨论了黄酮类化合物、三萜等植物成分的作用机理。类黄酮和三萜负载纳米颗粒似乎是一个很有前途的药物传递系统,特别是考虑到它在炎症性疾病中的管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Editorial Board Assessing variation among the drug-lists of 16 cities and impact on cardiovascular disease mortality: Evidence from Anhui Understanding AI adoption in the German pharmaceutical sector: Insights from expert interviews International expert consensus on hospital intelligent pharmacy Molecular recognition for anion detection: Progress and environmental significance
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1